Attovia Therapeutics, Inc.
ATTO
IPO
$22.86
-$0.80-3.38%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Net Income | -43.27% | -23.13% | |||
| Total Depreciation and Amortization | 18.84% | 69.23% | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | 820.91% | 67.84% | |||
| Change in Net Operating Assets | 72.69% | -2,032.14% | |||
| Cash from Operations | -33.62% | -28.38% | |||
| Capital Expenditure | 22.34% | 83.93% | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | 109.39% | 182.81% | |||
| Cash from Investing | 109.28% | 176.76% | |||
| Total Debt Issued | -- | -- | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | -68.37% | -75.56% | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -2,157.69% | -262.90% | |||
| Cash from Financing | -872.22% | -100.87% | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | 87.92% | -96.85% | |||